new glp-1 agonist glp 1 In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron, The Unstoppable Rise of GLP-1

Maintain energy levels and support metabolic processes, contributing to an active and balanced lifestyle

This is the unlikely journey from desert predator to medical marvel.

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide

A new case series presents a unique paradox where GLP-1 RA therapy improved quality of life and resolved diarrhea in two women with

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

Learn the benefits, risks and alternatives to GLP-1 weight loss drugs from the gray market to ensure you can treat your body and mind safely.